Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF

PHASE2RecruitingINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

July 29, 2022

Primary Completion Date

October 13, 2026

Study Completion Date

January 30, 2027

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

DWN12088

DWN12088 Xmg Tablet (BID)

DRUG

Placebo

Placebo 0mg Tablet (BID)

Trial Locations (30)

10475

RECRUITING

Myongji Hospital, Goyang-si

14584

RECRUITING

Soon Chun Hyang University Hospital Bucheon, Bucheon-si

14647

RECRUITING

The Catholic University of Korea, Bucheon St. Mary's Hospital, Bucheon-si

15213

RECRUITING

University of Pittsburgh Medical Center, Pittsburgh

16499

RECRUITING

Ajou University Hospital, Hwaseong-si

17033

RECRUITING

Penn State Milton S. Hershey Medical Center, Hershey

27403

RECRUITING

Pulmonix Research, LLC, Greensboro

27705

RECRUITING

Duke University Medical Center, Durham

29401

RECRUITING

The U.S. Department of Veterans Affairs, Charleston

29406

RECRUITING

Lowcountry Lung and Critical Care, Charleston

44033

RECRUITING

Ulsan University Hospital, Ulsan

47392

RECRUITING

Inje University Busan Paik Hospital, Busan

48109

RECRUITING

University of Michigan Health System, Michigan Center

60153

RECRUITING

Loyola University Medical Center (LUMC), Maywood

63017

RECRUITING

The Lung Research Center, LLC, Chesterfield

66160

RECRUITING

University of Kansas Medical Center Research Institute, Inc, Kansas City

75204

RECRUITING

Baylor Scott & White Research Institute, Dallas

77030

RECRUITING

Baylor College of Medicine, Houston

85013

RECRUITING

Dignity Health Norton Thoracic Institute, Phoenix

94143

RECRUITING

The University of California San Francisco, San Francisco

97232

RECRUITING

Legacy Research Institute, Portland

85206-1346

RECRUITING

Pulmonary Associates, PA, Mesa

02111

RECRUITING

Tufts Medical Center, Boston

02215

RECRUITING

Beth Israel Deaconess Medical Center, Boston

75390-9020

RECRUITING

The University of Texas Southwestern Medical Center, Dallas

78229-3901

RECRUITING

The University of Texas Health San Antonio Medical Arts & Research Center, San Antonio

03080

RECRUITING

Seoul National University Hospital, Seoul

03722

RECRUITING

Severance Hospital, Yonsei University Health System, Seoul

05505

RECRUITING

Asan Medical Center, Seoul

06351

RECRUITING

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY